Trastuzumab plus Paclitaxel or Docetaxel in...

The Oncologist 2008 / 04 Vol. 13; Iss. 4

Trastuzumab plus Paclitaxel or Docetaxel in HER-2-Negative/HER-2 ECD-Positive Anthracycline- and Taxane-Refractory Advanced Breast Cancer

Ardavanis, A., Kountourakis, P., Kyriakou, F., Malliou, S., Mantzaris, I., Garoufali, A., Yiotis, I., Scorilas, A., Baziotis, N., Rigatos, G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2007-0207
Date:
April, 2008
File:
PDF, 734 KB
english, 2008
Conversion to is in progress
Conversion to is failed